WO2010047559A2 - 방출성이 제어된 약제학적 제제 - Google Patents

방출성이 제어된 약제학적 제제 Download PDF

Info

Publication number
WO2010047559A2
WO2010047559A2 PCT/KR2009/006157 KR2009006157W WO2010047559A2 WO 2010047559 A2 WO2010047559 A2 WO 2010047559A2 KR 2009006157 W KR2009006157 W KR 2009006157W WO 2010047559 A2 WO2010047559 A2 WO 2010047559A2
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical formulations
present
effective
sustained
release pharmaceutical
Prior art date
Application number
PCT/KR2009/006157
Other languages
English (en)
French (fr)
Other versions
WO2010047559A3 (ko
Inventor
김성욱
전성수
구자성
장석영
이상주
Original Assignee
한올제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한올제약주식회사 filed Critical 한올제약주식회사
Publication of WO2010047559A2 publication Critical patent/WO2010047559A2/ko
Publication of WO2010047559A3 publication Critical patent/WO2010047559A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 베타 아드레날린 차단제와 HMG-CoA 환원효소 억제제를 포함하는 방출성이 제어된 약제학적 제제에 관한 것이다. 본 발명의 약제학적 제제는 상기 두 성분을 단일제로 각각 동시 복용하는 경우보다 약효를 증가시키고 부작용을 감소시킬 수 있을 뿐만 아니라 고지혈증, 관상 동맥 질환 등이 복합적으로 나타나는 환자들의 고혈압 치료와 합병증 예방에 효과적이며, 환자의 복약지도에 용이하다.
PCT/KR2009/006157 2008-10-23 2009-10-23 방출성이 제어된 약제학적 제제 WO2010047559A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080104481A KR20100045344A (ko) 2008-10-23 2008-10-23 방출성이 제어된 베타 아드레날린 차단제와 ＨＭＧ-ＣｏＡ 환원 효소 억제제의 신규 복합 조성물
KR10-2008-0104481 2008-10-23

Publications (2)

Publication Number Publication Date
WO2010047559A2 true WO2010047559A2 (ko) 2010-04-29
WO2010047559A3 WO2010047559A3 (ko) 2010-07-29

Family

ID=42119858

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/006157 WO2010047559A2 (ko) 2008-10-23 2009-10-23 방출성이 제어된 약제학적 제제

Country Status (2)

Country Link
KR (1) KR20100045344A (ko)
WO (1) WO2010047559A2 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012005500A3 (ko) * 2010-07-06 2012-05-03 주식회사 네비팜 다폭세틴을 포함하는 시간차 서방출 경구투여형 약학적 조성물

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140111982A (ko) * 2013-03-12 2014-09-22 주식회사 엘지생명과학 발사르탄 및 로수바스타틴 칼슘을 포함하는 복합 제제 및 이의 제조방법

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020086749A (ko) * 2000-04-03 2002-11-18 아스트라제네카 아베 베타 블록커 및 콜레스테롤 저하제의 신규한 조합물
KR100641638B1 (ko) * 2004-07-29 2006-11-02 보람제약주식회사 신규한 경구용 속/서방 복합 캡슐제제
KR20070078625A (ko) * 2006-01-27 2007-08-01 씨제이 주식회사 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법
KR20080032616A (ko) * 2006-10-10 2008-04-15 한올제약주식회사 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020086749A (ko) * 2000-04-03 2002-11-18 아스트라제네카 아베 베타 블록커 및 콜레스테롤 저하제의 신규한 조합물
KR100641638B1 (ko) * 2004-07-29 2006-11-02 보람제약주식회사 신규한 경구용 속/서방 복합 캡슐제제
KR20070078625A (ko) * 2006-01-27 2007-08-01 씨제이 주식회사 멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법
KR20080032616A (ko) * 2006-10-10 2008-04-15 한올제약주식회사 시간차 투약 원리를 이용한 심혈관계 질환 치료용 복합제제

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012005500A3 (ko) * 2010-07-06 2012-05-03 주식회사 네비팜 다폭세틴을 포함하는 시간차 서방출 경구투여형 약학적 조성물

Also Published As

Publication number Publication date
WO2010047559A3 (ko) 2010-07-29
KR20100045344A (ko) 2010-05-03

Similar Documents

Publication Publication Date Title
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
WO2007017135A3 (en) Process for the preparation of olmesartan medoxomil
WO2006037031A3 (en) Formulations and methods for treatment of inflammatory diseases
WO2009076170A3 (en) Combinations of therapeutic agents for treating cancer
MX2009004681A (es) Composicion compleja de liberacion controlada que comprende bloqueadores del receptor de angiotensina ii e inhibidores de hmg-coa-reductasa.
WO2010066684A3 (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
WO2006076620A3 (en) Bendamustine pharmaceutical compositions for lyophilisation
WO2007103435A3 (en) Bioavailable curcuminoid formulations for treating alzheimer's disease and other age-related disorders
WO2007084667A3 (en) Fused heterobicyclic kinase inhibitors
WO2008157537A3 (en) Compositions and methods of use for treating or preventing lipid related disorders
WO2008061226A3 (en) Sustained-release formulations of topiramate
WO2007096151A3 (en) Inhibitors of p38-kinase for treatment of pulmonary hypertension
WO2006108582A3 (en) Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis
WO2008086269A3 (en) 6-aminoisoquinoline compounds useful as kinase modulators
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
WO2007128086A3 (en) Novel viral replication inhibitor
WO2009022821A3 (en) Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the same
WO2010086860A3 (en) Neuroprotective multifunctional compounds and pharmaceutical compositions comprising them
UA96575C2 (en) Process for the preparation of olmesartan medoxomil
WO2006108680A3 (en) Substances and pharmaceutical compositions for the inhibition of glyoxalases and their use against protozoa and helminthes
WO2009099553A3 (en) Use of kinase inhibitor in treatment of atherosclerosis
WO2009041787A3 (en) Pharmaceutical composition comprising inhibitors of cell adhesion molecule isolated from piper nigrum for the prevention and treatment of inflammatory disease
WO2006050472A3 (en) Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
WO2007006790A3 (en) Combination of a dpp-iv inhibitor and a cannabinoid cb1 receptor antagonist
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09822235

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09822235

Country of ref document: EP

Kind code of ref document: A2